2016 Review "Multiple Sclerosis Industry" : Market Analysis, Trend, Share, Growth, Forecast 2019
Description- Executive Summary The global Multiple Sclerosis market is undergoing drastic change since the last few years. The rising diagnosis and treatment rate coupled with growing investment in research and development has played a key role in the determining the growth dynamics of the global Multiple Sclerosis (MS) market. Currently, MS is known to affect an estimated 2.5 million people around the world with around 5000 new cases emerging each year. Since there is no particular cure or treatment for multiple sclerosis, the market is currently dominated by few drugs and medication like Copaxone, Avonex, Betaseron and Extavia which delay or reduce the progression of multiple sclerosis in individuals. To Browse a Report Detail with TOC @ http://www.researchmoz.us/global-multiple-sclerosis-market-trends-and-opportunities-2013-18-report.html Until the last year, MS market was led by self injectables drugs such as Capaxone and Avonex that caused side effects l